# Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** RFA-NS-26-001
- **Status:** posted
- **Opens:** May 4, 2026
- **Closes:** November 10, 2026
- **CFDA:** 93.853
- **View on Kontrakk:** https://kontrakk.com/grants/360400

## Description

No description provided.